|
1
|
Costa MA and Simon DI: Molecular basis of
restenosis and drug-eluting stents. Circulation. 111:2257–2273.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Lafont A and Libby P: The smooth muscle
cell: Sinner or saint in restenosis and the acute coronary
syndromes? J Am Coll Cardiol. 32:283–285. 1998.PubMed/NCBI
|
|
3
|
Spaulding C, Henry P, Teiger E, Beatt K,
Bramucci E, Carrié D, Slama MS, Merkely B, Erglis A, Margheri M, et
al: Sirolimus-eluting versus uncoated stents in acute myocardial
infarction. N Engl J Med. 355:1093–1104. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Stone GW, Lansky AJ, Pocock SJ, Gersh BJ,
Dangas G, Wong SC, Witzenbichler B, Guagliumi G, Peruga JZ, Brodie
BR, et al: Paclitaxel-eluting stents versus bare-metal stents in
acute myocardial infarction. N Engl J Med. 360:1946–1959. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Serruys PW, Silber S, Garg S, van Geuns
RJ, Richardt G, Buszman PE, Kelbaek H, van Boven AJ, Hofma SH,
Linke A, et al: Comparison of zotarolimus-eluting and
everolimus-eluting coronary stents. N Engl J Med. 363:136–146.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Luscher TF, Steffel J, Eberli FR, Joner M,
Nakazawa G, Tanner FC and Virmani R: Drug-eluting stent and
coronary thrombosis: Biological mechanisms and clinical
implications. Circulation. 115:1051–1058. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Chen J, Han Y, Lin C, Zhen Y, Song X, Teng
S, Chen C, Chen Y, Zhang Y and Hui R: PDGF-D contributes to
neointimal hyperplasia in rat model of vessel injury. Biochem
Biophys Res Commun. 329:976–983. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Nurminskaya M, Beazley KE, Smith EP and
Belkin AM: Transglutaminase 2 promotes PDGF-mediated activation of
PDGFR/Akt1 and β-catenin signaling in vascular smooth muscle cells
and supports neointima formation. J Vasc Res. 51:418–428. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Zimmermann O, Zwaka TP, Marx N, Torzewski
M, Bucher A, Guilliard P, Hannekum A, Hombach V and Torzewski J:
Serum starvation and growth factor receptor expression in vascular
smooth muscle cells. J Vasc Res. 43:157–165. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kappert K, Paulsson J, Sparwel J, Leppänen
O, Hellberg C, Ostman A and Micke P: Dynamic changes in the
expression of DEP-1 and other PDGF receptor-antagonizing PTPs
during onset and termination of neointima formation. FASEB J.
21:523–534. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Demetri GD, van Oosterom AT, Garrett CR,
Blackstein ME, Shah MH, Verweij J, McArthur G, Judson IR, Heinrich
MC, Morgan JA, et al: Efficacy and safety of sunitinib in patients
with advanced gastrointestinal stromal tumour after failure of
imatinib: A randomised controlled trial. Lancet. 368:1329–1338.
2006. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Motzer RJ, Hutson TE, Tomczak P,
Michaelson MD, Bukowski RM, Oudard S, Negrier S, Szczylik C, Pili
R, Bjarnason GA, et al: Overall survival and updated results for
sunitinib compared with interferon alfa in patients with metastatic
renal cell carcinoma. J Clin Oncol. 27:3584–3590. 2009. View Article : Google Scholar
|
|
13
|
Ishii S, Okamoto Y, Katsumata H, Egawa S,
Yamanaka D, Fukushima M and Minami S: Sunitinib, a small-molecule
receptor tyrosine kinase inhibitor, suppresses neointimal
hyperplasia in balloon-injured rat carotid artery. J Cardiovasc
Pharmacol Ther. 18:359–366. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Zohlnhöfer D, Hausleiter J, Kastrati A,
Mehilli J, Goos C, Schühlen H, Pache J, Pogatsa-Murray G, Heemann
U, Dirschinger J and Schömig A: A randomized, double-blind,
placebo-controlled trial on restenosis prevention by the receptor
tyrosine kinase inhibitor imatinib. J Am Coll Cardiol.
46:1999–2003. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Chen YX, Ma X, Whitman S and O'Brien ER:
Novel antiinflammatory vascular benefits of systemic and
stent-based delivery of ethylisopropylamiloride. Circulation.
110:3721–3726. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lankheet NA, Steeghs N, Rosing H,
Schellens JH, Beijnen JH and Huitema AD: Quantification of
sunitinib and N-desethyl sunitinib in human EDTA plasma by liquid
chromatography coupled with electrospray ionization tandem mass
spectrometry: Validation and application in routine therapeutic
drug monitoring. Ther Drug Monit. 35:168–176. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Andrés-Manzano MJ, Andrés V and Dorado B:
Oil Red O and Hematoxylin and eosin staining for quantification of
atherosclerosis burden in mouse aorta and aortic root. Methods Mol
Biol. 1339:85–99. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Schwartz RS, Edelman E, Virmani R, Carter
A, Granada JF, Kaluza GL, Chronos NA, Robinson KA, Waksman R,
Weinberger J, et al: Drug-eluting stents in preclinical studies:
Updated consensus recommendations for preclinical evaluation. Circ
Cardiovasc Interv. 1:143–153. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Hong MK, Kornowski R, Bramwell O, Ragheb
AO and Leon MB: Paclitaxel-coated Gianturco-Roubin II (GR II)
stents reduce neointimal hyperplasia in a porcine coronary in-stent
restenosis model. Coron Artery Dis. 12:513–515. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Kok SH, Gambari R, Chui CH, Lau FY, Cheng
GY, Lai PB, Lam WS, Chan AS, Cheng CH, Teo IT, et al: Paradoxical
proliferative potential of iron (II) sulphate on cancer cells after
the
3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
(MTS) assay. Int J Mol Med. 19:971–975. 2007.PubMed/NCBI
|
|
21
|
Jandt E, Mutschke O, Mahboobi S, Uecker A,
Platz R, Berndt A, Böhmer FD, Figulla HR and Werner GS: Stent-based
release of a selective PDGF-receptor blocker from the
bis-indolylmethanon class inhibits restenosis in the rabbit animal
model. Vascul Pharmacol. 52:55–62. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Seo J, Lee HS, Ryoo S, Seo JH, Min BS and
Lee JH: Tangeretin, a citrus flavonoid, inhibits PGDF-BB-induced
proliferation and migration of aortic smooth muscle cells by
blocking AKT activation. Eur J Pharmacol. 673:56–64. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Raines EW: PDGF and cardiovascular
disease. Cytokine Growth Factor Rev. 15:237–254. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Hua Y, Dolence J, Ramanan S, Ren J and
Nair S: Bisdemethoxycurcumin inhibits PDGF-induced vascular smooth
muscle cell motility and proliferation. Mol Nutr Food Res.
57:1611–1618. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Murrell M, Khachigian L and Ward MR: The
role of c-jun in PDTC-sensitive flow-dependent restenosis after
angioplasty and stenting. Atherosclerosis. 194:364–371. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Jia L, Wang R and Tang DD: Abl regulates
smooth muscle cell proliferation by modulating actin dynamics and
ERK1/2 activation. Am J Physiol Cell Physiol. 302:C1026–C1034.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Cai Y, Knight WE, Guo S, Li JD, Knight PA
and Yan C: Vinpocetine suppresses pathological vascular remodeling
by inhibiting vascular smooth muscle cell proliferation and
migration. J Pharmacol Exp Ther. 343:479–288. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Joner M, Finn AV, Farb A, Mont EK,
Kolodgie FD, Ladich E, Kutys R, Skorija K, Gold HK and Virmani R:
Pathology of drug eluting stents in humans: Delayed healing and
late thrombotic risk. J Am Coll Cardiol. 48:193–202. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Finn AV, Nakazawa G, Joner M, Kolodgie FD,
Mont EK, Gold HK and Virmani R: Vascular responses to drug eluting
stents: Importance of delayed healing. Arterioscler Thromb Vasc
Biol. 27:1500–1510. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Nakazawa G, Finn AV, Joner M, Ladich E,
Kutys R, Mont EK, Gold HK, Burke AP, Kolodgie FD and Virmani R:
Delayed arterial healing and increased late stent thrombosis at
culprit sites after drug-eluting stent placement for acute
myocardial infarction patients: An autopsy study. Circulation.
118:1138–1145. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Houtgraaf JH and Duckers HJ: Endothelial
progenitor cell (EPC) capture to aid vascular repair following
coronary stenting: A new frontier in stent technology?
EuroIntervention. 4:C67–C71. 2008.PubMed/NCBI
|
